Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
5/13/2026
Strategic Partnerships Redefine China's Biotech Innovation Model: CBPF
5/12/2026
Singapore, China Expand Regulatory Partnership to Include Gene and Cel...
5/12/2026
Virax Eyes China Expansion for T-Cell Immune Profiling Platform
5/12/2026
BrightGene Reports Phase 3 Success for Dual GLP-1/GIP Obesity Drug BGM...
5/12/2026
Sihuan Pharma Completes Full H-Share Conversion of Xuanzhu Biopharm
5/12/2026
China Moves to Expand Maternity Insurance Coverage and Birth-Related B...
5/12/2026
China Expands National Pediatric Medical Center Network to Strengthen ...
5/12/2026
China Holds National Healthcare Reform Meeting, Prioritizes Public Hos...
5/12/2026
BMS Strikes Up to $15.2B Hengrui Alliance to Accelerate Global Drug De...
5/12/2026
China Approves Novel EGFR, JAK2 Therapies as Wave of Innovative INDs A...
5/12/2026
CureGene Raises Over CNY 300M in Series C Led by Walvax
5/12/2026
Resproly Raises New Funding to Advance Inhalation Pipeline
5/12/2026
DualityBio Reports Strong First-Line TNBC Data for DB-1305/BNT325 Plus...
5/12/2026
Starna Raises ~US$40M in Series B+ to Advance In Vivo CAR-T and Extrah...
5/12/2026
CytoCares Reports First-in-Human AACR Data for CD19/CD3/CD28 Trispecif...
5/12/2026
BeOne Culls Multiple Early Oncology Programs, Halts Phase 2 IRAK4 Degr...
5/12/2026
Sinocelltech Advances Dual Trispecific Antibody Combo Into Phase 1b/2 ...
5/11/2026
CDE Releases Draft MSC Stem Cell Product Guideline for Public Consulta...
5/11/2026
NMPA Releases 105th Batch of Generic Drug Reference Formulations
5/11/2026
NHSA Seeks Comments on 2026 NRDL and Commercial Innovation Drug List A...
5/11/2026
Bundxcell Completes A+ Financing to Advance iPSC-Based Regenerative Me...
5/11/2026
NHC Seeks Comments on Revised Human Genetic Resources Regulation Imple...
5/8/2026
Recent Executive Moves
5/8/2026
CDE Issues Revised Technical Guideline for Recombinant Insulin Product...
5/8/2026
China Reports 3.05M ADRs in 2025, Flags Oncology and Anti-Infective Ri...
5/8/2026
China Unveils Tougher Nationwide Rules Governing Medical Representativ...
5/8/2026
Viatris Tops Quarterly Estimates on Strong China Performance and Brand...
5/8/2026
China Poised to Lead Next Wave of CAR-T Innovation in Solid Tumors, Sa...
5/8/2026
InnoCare Advances CDH17 ADC Into Clinic as Competition Builds in GI Ca...
5/8/2026
LTZ Thera Raises $38M to Advance Myeloid-Engager Immunotherapy Pipelin...
Page:
1
/
62
Total number of articles:
1853
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit